Innovation to Develop (I2D)
Funding the development of an innovation to a commercialisable endpoint
This funding is for an ambitious, deliverable development plan to take an innovation to a commercialisable endpoint. A funding application must clearly illustrate the technical feasibility of the project and demonstrate the potential for translation to a point where the technology would be attractive to an industry partner or follow-on funder.
Funding is considered if the application satisfies the following criteria:
- Strong intellectual property position
- Preliminary proof of-concept data in in vitro and/or in vivo research/laboratory models
- Detailed development plan highlighting future project work, milestones, endpoints
- Clear and achievable commercial plan outlining the unmet healthcare need, the proposed route to market, competing technologies and potential industry partners
- Would result in significant healthcare or services cost savings
This category will provide a funding quantum capped at S$250,000 (inclusive of max. 20% indirect costs) awarded to the host institution (which will be responsible for reimbursing costs incurred by collaborating institutions and industry partners).
The funding support is up to 1 year.
The Principal Investigator must hold a primary appointment in a public hospital/public health institution/national speciality centre/Academic Medical Centre/medical school in Singapore and be salaried by the institution. Project teams must contain strong clinical representation. Collaborations with industry are encouraged if they strengthen the proposal. All applications are judged on merit and eligibility is not limited to NMRC-funded research.
For any queries concerning eligibility, please contact the NHIC I2D Grant Secretariat at email@example.com.
Terms and Conditions
For the Terms and Conditions governing NHIC grants, please see Terms and Conditions.
Closing dates for 2017 are:
- 7th April 2017
- 4th August 2017
- 1st December 2017
Please note that the Research/Innovation office of your respective Healthcare Cluster may have internal deadlines for NHIC grant calls.
I2D review period (from pre-proposal submission to Award Letter) is 16 weeks.
Please note that only one application per Principal Investigator can be submitted per grant call. Applications can be resubmitted only once.
NHIC I2D Pre-Proposal Applications must be endorsed, signed and submitted electronically by the Research/Innovation Office of your respective Healthcare Cluster to the NHIC Grant Secretariat at firstname.lastname@example.org.
For further information on our process, please see How we work.